Home > Boards > US OTC > Medical - Equipment >

Cerebain Biotech Corp. (CBBT)

Add CBBT Price Alert      Hide Sticky   Hide Intro
Moderator: Golden_Cross, BeardOfWallSt, Kid-Gloves, $Pistol Pete$, Chrisny73, TAB78
Search This Board: 
Last Post: 10/15/2019 1:44:25 AM - Followers: 194 - Board type: Free - Posts Today: 2


Cerebain has a patent-pending device that is implanted in the omentum, a protective layer of skin that protects the abdominal organs. The device is designed to stimulate the omentum in patients with Alzheimer’s Disease. Omental stimulation has been shown to improve cognitive function in patients with dementias, including Alzheimer’s Disease.

Cerebain will evaluate the effect of omental stimulation at different intervals and levels of stimulation to determine the device’s ability to slow, stop or reverse the progression of Alzheimer’s Disease on patients.

About the Omentum

Generally described as a protective layer in the abdomen, the omentum covers the intestines, hangs on to the stomach and can be lifted like a flap. While the omentum is not a well-recognized body part, it can play important healing and protective roles for its host.

Protection: The omentum has abundant blood and lymphatic vessels, and can move flexibly throughout the abdomen to protect organs from threat and injury.

Healing: Additionally, it contains the largest supply of stem cells in the adult body. Because of its abundant blood supply, surgeons have long used the omentum to patch internal injuries sustained to other parts of the body.

Cerebain’s Technology

Patent-pending technology has allowed for the development of a medical device that can
be implanted using a minimally invasive procedure.

Once implanted via what will probably be a same-day surgery procedure, patients may not have to undergo surgery again using this treatment method.

Cerebain has a manufacturing agreement with Sonos Medical, a trusted and reliable medical device supplier.

Clinical Trials

The Company is now in the process of preparing for initial clinical trials that will most likely occur at multiple medical centers in Europe.

Potential for a Personalized Approach to
Treatment for Alzheimer’s Disease Patients

As clinical trials are conducted and variables are put into play (e.g., frequency of stimulation, duration, location, etc.,) we may find that individuals respond differently and require individualized treatment plans. Cerebain’s device can potentially provide this, making our ability to positively impact the lives of as many Alzheimer’s Disease patients as possible.

In 2010 Cerebain Biotech licensed patent-pending technology for an implantable device that stimulates the omentum, and can be adjusted non-invasively to account for a range of factors, including frequency, strength of stimulation and location.


Company Overview

Existing therapeutics have been unable to halt disease progression or extend life in a meaningful way

Cerebain’s novel device approach is supported by research and patient outcomes

Clinical evidence supports the Company’s working approach, that omentum stimulation improves cognitive function in patients with dementia, including Alzheimer’s Disease

Minimally invasive, one-time device implantation will overcome challenges associated with previous omentum stimulation procedures that are highly invasive

Patent-pending technology with broad applicability

Recent scientific breakthroughs regarding the potential identification of gene-specific protein increases prior to on-set of symptoms, could compliment our work

Early diagnosis is key to helping patients maintain quality of life http://www.nia.nih.gov/alzheimers/publication/alzheimers-disease-genetics-fact-sheet

Experienced management and advisory teams with the expertise to move the clinical program forward efficiently and effectively


Corporate Leadership


Eric Clemons, President and CEO
e-mail:  clemons@cerebain.com

Mr. Clemons has a long history building and growing companies across multiple industries. Prior to assuming leadership of Cerebain, he served as President and Chief Operating Officer for GTC Telecom Corp, a publicly traded Nevada Corporation that operated out of Costa Mesa, CA. During his tenure, Mr. Clemons was instrumental in growing the company’s annual revenues from $500,000 per year to over $17 million per year.

It was Cerebain technology, which offers a completely new way of approaching the development of an effective Alzheimer’s disease treatment that captured Mr. Clemons’ imagination, triggering his move into the life sciences arena.

“While there have been some very recent key learnings in the Alzheimer’s treatment space, the fact is that the disease remains the only top ten killer in the United States with no effective treatments currently available and no way to halt or slow progression,” Clemons said. “We are hopeful that our device, which will focus on the impact of omental stimulation and cognitive function in Alzheimer’s Disease patients, can change that.”

Wesley Tate – Chief Financial Officer
e-mail:  wtate@cerebain.com

Prior to joining Cerebain Biotech, Mr. Tate was the owner of Strategic Business Associates, a Tennessee-based consultancy offering business management and growth services to start-up and early-stage companies.

Over the course of his career Mr. Tate has held key managerial positions at both healthcare and telecoms companies. This includes Chief Financial Officer for HST Global, Inc., a development-stage biotechnology company located in Virginia; and Executive Vice President and Chief Operating Officer for InnerLight Inc., a life science company located in Utah.

Mr. Tate received his Bachelor of Science degree from the University of Tennessee, Knoxville, with majors in Finance and Psychology, and earned his Masters of Business Administration from the University of Tennessee, Knoxville, with concentrations in Finance and Management.

He is proud to have served his country as a member of the United States Army.


Held at DTC
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#6987  Sticky Note On Wed, Aug 7, 2019, 11:25 AM CEREBAIN TAB78 09/21/19 09:22:01 PM
#3947  Sticky Note $CBBT check out this link and see CBBT $Pistol Pete$ 07/11/19 08:25:23 PM
#3616  Sticky Note $CBBT Current Filings and Share Structure: Golden_Cross 06/23/19 01:40:23 PM
#8425   The herd is easily spooked and they don’t jerrybrockman 10/15/19 01:44:25 AM
#8424   Last of the cheapies to grab tomorrow morning. MotorCityMuscle 10/15/19 12:12:19 AM
#8423   Silence before the storm, is what we're seeing TAB78 10/14/19 11:04:02 PM
#8422   Well I can say this.... this CEO is RMS555 10/14/19 07:34:03 PM
#8421   There was a shift in the trading today TAB78 10/14/19 07:09:24 PM
#8420   the new sfo designation from the fda alone daveymoore 10/14/19 06:18:19 PM
#8419   Kinda figured it would of stayed even today, RMS555 10/14/19 04:02:52 PM
#8418   Thanks Dcab 10/14/19 03:39:53 PM
#8417   Had no idea what it was fonna do TAB78 10/14/19 03:18:27 PM
#8416   No, they have one extension of 15 days, TAB78 10/14/19 03:16:14 PM
#8415   Interesting trading day today... nice buying at open, RMS555 10/14/19 02:46:58 PM
#8414   V-painful, think he’s got it too-V jerrybrockman 10/14/19 01:12:03 PM
#8413   Mostly sellers this morning. Dcab 10/14/19 12:59:35 PM
#8412   Can this run like celz. Inve$tor77 10/14/19 12:43:15 PM
#8411   This was .07 52 week high. Inve$tor77 10/14/19 12:42:31 PM
#8410   10k should be tomorrow by end of day RMS555 10/14/19 12:14:24 PM
#8409   When is the 10K and what is a ed66 10/14/19 12:02:01 PM
#8408   I agree and investors as well. When companies MotorCityMuscle 10/14/19 11:52:14 AM
#8407   Good Morning CBBT.... fly_fisherman 10/14/19 11:35:03 AM
#8406   $CBBT DD links WALL$TREET 10/14/19 10:54:38 AM
#8405   Thats exactly what I watch... bid size drops RMS555 10/14/19 10:24:38 AM
#8404   DRY UP ON FLUSH SIDE === MOVING UP Tonyeight 10/14/19 10:17:01 AM
#8403   They let it build hoping to get 001, m_m007 10/14/19 10:16:14 AM
#8402   Once we blast through .0018s. Clear skies Inve$tor77 10/14/19 10:14:27 AM
#8401   on Oct 3rd I sat and watched the RMS555 10/14/19 10:13:31 AM
#8400   Hit the ask peep, this one is m_m007 10/14/19 10:01:12 AM
#8399   Don't know, I would have to resewrch that one TAB78 10/14/19 09:56:23 AM
#8398   Sweet, I am off today, Holiday running errands TAB78 10/14/19 09:55:47 AM
#8397   Nice.... someone was in a hurry to grab RMS555 10/14/19 09:34:22 AM
#8396   they already did on October 1st, they have RMS555 10/14/19 09:22:04 AM
#8395   Can they file for an extension? Dcab 10/14/19 09:15:06 AM
#8394   I'm ready for this week..... I am still RMS555 10/14/19 08:34:01 AM
#8393   Thanks, will try from computer later, for some TAB78 10/14/19 08:22:16 AM
#8392   Good morning CBBT TAB78 10/14/19 08:16:38 AM
#8391   Don't know, tomorrow is 15th. 10K should TAB78 10/14/19 08:15:33 AM
#8390   One day until the 10K drops here and MotorCityMuscle 10/14/19 07:17:09 AM
#8389   idk, im so used to getting up every RarityLovesAll 10/13/19 10:55:35 PM
#8388   Ouch! Not the tattoo, but missing the RMS555 10/13/19 10:51:09 PM
#8387   going to miss the opening action tomorrow getting RarityLovesAll 10/13/19 09:35:03 PM
#8386   Ive been getting all 001’s loaded and ready m_m007 10/13/19 09:29:53 PM
#8385   I'm expecting .004 to hit. No idea if MotorCityMuscle 10/13/19 09:28:30 PM
#8384   Tomorrow we will see 0018 again m_m007 10/13/19 08:50:49 PM
#8383   It's ok, I am hit or miss a TAB78 10/13/19 08:25:19 PM
#8381   Lol... I know exactly what you are talking about! RMS555 10/13/19 08:06:17 PM
#8380   Dude, this is barely a blip on the jerrybrockman 10/13/19 07:46:36 PM
#8379   I think so too with all the loading Walterwhite666 10/13/19 06:52:03 PM
#8378   I tend to agree on that one Jerry. MotorCityMuscle 10/13/19 06:46:15 PM
#8377   Looking forward to tomorrow Walter... This week is MotorCityMuscle 10/13/19 06:44:24 PM
#8376   I’d bet the house that they are. jerrybrockman 10/13/19 06:43:44 PM
#8375   Hope everyone is enjoying their Sunday. $cbbt Walterwhite666 10/13/19 06:34:41 PM